Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
Luz-Veiga, Azevedo-Silva, Fernandes, João C., Mariana Luz-Veiga, João Azevedo-Silva, João C. Fernandes
Although there is a lack of strong evidence on the efficacy of cannabinoids for the treatment of RA and other rheumatic diseases, cannabinoids have been seen as a potential therapy due to their anti-inflammatory effects. Indeed, RA is included in the list of conditions eligible for receiving medical cannabis in several countries and most patients with arthritis taking cannabinoids on a regularly basis report beneficial effects, such as less pain and an opioid-sparing effect [ 189 ]. In vitro and animal experimentation results have been the main source of data used so far to support cannabinoids potential therapeutic effect on RA. Gui and co-workers demonstrated the expression of CB2 receptor in synovial tissue from patients with RA, and its specific activation revealed inhibitory effects on fibroblast-like synoviocytes [ 190 ]. The same team demonstrated that the activation of CB2 in collagen-induced arthritis in mice, using HU-308 (a CBD-derivative drug that acts as a potent cannabinoid agonist) has therapeutic potential for RA to suppress synovitis and alleviate joint destruction by inhibiting the production of autoantibodies and proinflammatory cytokines [ 191 ].
Tags:
- Cannabidiol
- Inflammatory bowel disease
- Cannabinoid
- Lupus
- Cannabinoid receptor type 2
- Tetrahydrocannabinol
- Psoriasis
- Inflammation
- TRPV1
- Apoptosis
- Endocannabinoid system
- Cannabinoid receptor type 1
- Cancer
- Cannabinoid receptor
- Reactive oxygen species
- Dose (biochemistry)
- Biochemistry
- Diseases and disorders
- Neurochemistry
- Cell biology
- Health
- Medicine
- Medical specialties
- Clinical medicine